Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Professional Posters
All Days
Mon, Dec 5
Tue, Dec 6
Professional Posters
Type here to filter the list
Monday, December 5, 2022
2:00 PM – 3:30 PM
(4-028) Analysis of Factors Affecting Medication Adherence of Geriatric Outpatients Using the Self-reported Questionnaire
Favorite
2:00 PM – 3:30 PM
(4-066) Analysis of Unpredictable Adverse Drug Reaction in Elderly Patients and Drug Assessment
Favorite
2:00 PM – 3:30 PM
(4-018) Application of a Common Bioassay to Measure Deactivation of Beta-lactam Antibiotics
Favorite
2:00 PM – 3:30 PM
(4-033) Assessing awareness and Implementation of Herpes Zoster Vaccine Recommendations by Subspecialists in the United States
Favorite
2:00 PM – 3:30 PM
(4-044) Biosimilar Uptake and Cost Savings Analysis Before and After Implementation of a Pharmacist-driven Substitution Program Within a National Community Oncology Network
Favorite
2:00 PM – 3:30 PM
(4-046) Budget Impact Analysis and Cost Savings of Trastuzumab Biosimilar for the Treatment of Breast Cancer at a Tertiary Cancer Center in the United Arab Emirates
Favorite
2:00 PM – 3:30 PM
(4-007) Characterization of the New Orleans Syringe Access Program (NOSAP) Participants During the Initial Months of the Coronavirus Disease 2019 (COVID-19) Naloxone Education and Distribution Services
Favorite
2:00 PM – 3:30 PM
(4-026) Climate Change and Environmental Sustainability Actions of the Pharmaceutical Industry
Favorite
2:00 PM – 3:30 PM
(4-025) Clinical Management of Acute Agitation in Patients with Schizophrenia or Bipolar Disorder in Emergency Departments in the United States – a Retrospective Chart Review
Favorite
2:00 PM – 3:30 PM
(4-035) Clostridioides Difficile: A Recurrent Infection with Broad Economic Consequences for US Hospitals
Favorite
2:00 PM – 3:30 PM
(4-030) Collaboration Between a Family Medicine Clinic and Specialty Pharmacy to Administer Vaccines Under Medicare Part D During Home Based Primary Care Visits
Favorite
2:00 PM – 3:30 PM
(4-005) Correction of Warfarin Coagulopathy for Non-bleeding Patients in the Outpatient Setting at an Ambulatory Care Organization: Application of Vitamin K Guidance
Favorite
2:00 PM – 3:30 PM
(4-059) Developing a Virtual Formulary Education Program for Fifth-year Pharmacy Students During an Experiential Hospital Practice Training in an Academic Teaching Hospital in Japan
Favorite
2:00 PM – 3:30 PM
(4-057) Development and Accreditation of a Pharmacy Technician Training Program Within an Academic Healthcare System
Favorite
2:00 PM – 3:30 PM
(4-064) Development and Implementation of a Multimodal Propofol Storage Security Plan at a Large Health System
Favorite
2:00 PM – 3:30 PM
(4-038) Development of Best Practices for Smart Pump Drug Library Pertaining to Neonatal and Infant Continuous Infusions
Favorite
2:00 PM – 3:30 PM
(4-016) Does Focused Education on the Use of Proton Pump Inhibitors (PPIs) Reduce the Incidence of Acute Upper Gastrointestinal Bleeding (aUGIB) in Patients on Antithrombotic Therapy?
Favorite
2:00 PM – 3:30 PM
(4-032) Efficacy and Safety of Investigational Microbiota-based Live Biotherapeutic RBX2660 in Individuals with Recurrent Clostridioides difficile Infection from 5 Prospective Clinical Studies: An Update
Favorite
2:00 PM – 3:30 PM
(4-020) Establishing a Rifaximin Criteria for Use Protocol for Hepatic Encephalopathy
Favorite
2:00 PM – 3:30 PM
(4-042) Evaluating the Use of Blinatumomab Use in a Lebanese Tertiary Care Teaching Hospital
Favorite
2:00 PM – 3:30 PM
(4-068) Evaluation a Tetanus Immunization Screening Program Implementation in the Emergency Room Department of a Rural Medical Center
Favorite
2:00 PM – 3:30 PM
(4-045) Evaluation of a Fixed-dose Rasburicase Protocol for Treatment of Hyperuricemia at a Community Medical Center
Favorite
2:00 PM – 3:30 PM
(4-013) Evaluation of Direct Oral Anticoagulant Use Following Surgical Bioprosthetic Valve Replacement
Favorite
2:00 PM – 3:30 PM
(4-062) Evaluation of Door-to-needle Times for Intravenous Tissue Plasminogen Activator Before and After the Implementation of an Updated Interdisciplinary Code Stroke Process
Favorite
2:00 PM – 3:30 PM
(4-073) Evaluation of Perceived Stress and Lifestyle Choices Among U.S. Pharmacy Students at the Beginning of the COVID-19 Pandemic
Favorite
2:00 PM – 3:30 PM
(4-040) Exploratory Study on Effect of Repackaging Intravenous Cetirizine Hydrochloride Solution into Syringes on Drug Stability and Microbial Challenge Hold Time
Favorite
2:00 PM – 3:30 PM
(4-041) Extended Dating of IV Bags Utilizing Low Density Polyethylene Overwrap
Favorite
2:00 PM – 3:30 PM
(4-008) Financial Reimbursement and Productivity Metrics for Pharmacist-led Chronic Care Management Services in Rural Practice Settings
Favorite
2:00 PM – 3:30 PM
(4-051) Gastrointestinal Adverse Effects Associated with the Use of Intravenous Oliceridine Compared to Intravenous Hydromorphone or Fentanyl in Acute Pain Management Utilizing Indirect Treatment Comparison Methods
Favorite
2:00 PM – 3:30 PM
(4-009) Glycemic Impact of Janus Kinase Inhibitors in Diabetic Patients with Immune-mediated Rheumatic Diseases
Favorite
2:00 PM – 3:30 PM
(4-023) High Dose Epoetin Alpha in Jehovah’s Witness Patients with Critically Low Hemoglobin Levels
Favorite
2:00 PM – 3:30 PM
(4-029) Hospital at Home: Evidence to Support the Use of a Home Infusion Pharmacy
Favorite
2:00 PM – 3:30 PM
(4-036) Impact of a Ceftolozane/tazobactam Shortage in a Long-term Acute Care Hospital System
Favorite
2:00 PM – 3:30 PM
(4-063) Impact of a Pharmacist-led Transgender Men Health Education Group on Gender-affirming Hormone Therapy and Mental Health Disparities Among Veterans
Favorite
2:00 PM – 3:30 PM
(4-047) Impact of a Pharmacy Diversion Detection Program for Controlled Substance Use in Procedural Areas
Favorite
2:00 PM – 3:30 PM
(4-061) Impact of Latent Tuberculosis Treatment and Psychiatric Medication Interactions in a Long-term Psychiatric Facility
Favorite
2:00 PM – 3:30 PM
(4-001) Impact of Par Adjustments on Inventory Turnover Ratios at an Ambulatory Infusion Center
Favorite
2:00 PM – 3:30 PM
(4-010) Implementation and Outcomes of a Collaborative Drug Therapy Management Program in a Large Public Health Care System in the United States
Favorite
2:00 PM – 3:30 PM
(4-034) Implementation of a Restricted Antimicrobial Review Process Within a Long-term Acute Care Hospital
Favorite
2:00 PM – 3:30 PM
(4-002) Implementation of Centralized Product Defect Reporting for Cost Recovery Across Campuses
Favorite
2:00 PM – 3:30 PM
(4-065) Implementation of Outpatient COVID-19 Therapeutic Prophylaxis, and Treatments at a Mid-size Community Hospital
Favorite
2:00 PM – 3:30 PM
(4-055) Implementation of Reformatted Titration Orders to Comply with Joint Commission’s Medication Management (MM) Chapter MM.04.01.01
Favorite
2:00 PM – 3:30 PM
(4-015) Incidence of Alteplase Utilization for Central Venous Access De-clotting in Patients with Active COVID-19
Favorite
2:00 PM – 3:30 PM
(4-022) Interventions to Improve Methylprednisolone Injection Use in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
Favorite
2:00 PM – 3:30 PM
(4-071) Management of Patients with Multiple Sclerosis Within Health-system Specialty Pharmacies: Patient Reported Outcomes
Favorite
2:00 PM – 3:30 PM
(4-058) Mentoring Program for Hospital Pharmacists Involved in Pharmaceutical Management: Assessment of the First Cohort
Favorite
2:00 PM – 3:30 PM
(4-012) Metoprolol and CYP2D6: A Retrospective Cohort Study Evaluating Genotype-based Outcomes
Favorite
2:00 PM – 3:30 PM
(4-069) Naloxone & Opioid Overdose Terminology Preferences Among Rural Caregivers: Differences by Race
Favorite
2:00 PM – 3:30 PM
(4-048) Opioid-free Recovery After Inguinal Hernia Repair with Bupivacaine and Meloxicam Extended Release Solution as the Foundation of a Multimodal Analgesia Regimen in a Real-world Setting
Favorite
2:00 PM – 3:30 PM
(4-006) Patient Satisfaction with Point of Care Testing (POCT) for Hemoglobin a1c (HbA1c) at an Academic Medical Center Serving a Rural Population
Favorite
2:00 PM – 3:30 PM
(4-011) Patients Who Require Invasive Procedures While Receiving P2Y12 Inhibitors Incur Greater Healthcare Resource Utilization and Costs
Favorite
2:00 PM – 3:30 PM
(4-074) Pharmacy Integration into the Fertility Service Line: University Hospitals Specialty Pharmacy
Favorite
2:00 PM – 3:30 PM
(4-019) Pharmacy-led transitions of care service to increase empagliflozin prescribing rates in patients with heart failure and/or ischemic stroke at a public urban teaching hospital
Favorite
2:00 PM – 3:30 PM
(4-072) Photoinitiators Including Injection Solution Induce Breast Tumor Growth in Mouse Xenografts with MCF-7 Breast Cancer Cells
Favorite
2:00 PM – 3:30 PM
(4-003) Planning and Relocation of the Pharmacy of a Mother-child University Health Center
Favorite
2:00 PM – 3:30 PM
(4-014) Real-world Risk of Medullary Thyroid Carcinoma with GLP-1 Receptor Agonist Use: A Review
Favorite
2:00 PM – 3:30 PM
(4-017) Reducing Inpatient Intravenous Iron Use in a Community Hospital
Favorite
2:00 PM – 3:30 PM
(4-027) Reversal of anticoagulation in orthogeriatric patients with hip fracture requiring early surgical intervention
Favorite
2:00 PM – 3:30 PM
(4-049) Safely and Effectively Utilizing Opioid Pain Medications in Patients Taking Buprenorphine
Favorite
2:00 PM – 3:30 PM
(4-004) Survey of Hospital Pharmacy Practice in Canada – 1985-86 to 2020-21
Favorite
2:00 PM – 3:30 PM
(4-021) Switching to the Most Cost Effective Infliximab in a County Health System
Favorite
2:00 PM – 3:30 PM
(4-037) Synergistic Activity Evaluation of Aztreonam in Combination with Ceftazidime-avibactam for Treatment of Resistant Stenotrophomonas Maltophilia in Patients with Cystic Fibrosis using a One-compartment Pharmacokinetic Model
Favorite
2:00 PM – 3:30 PM
(4-052) Systematized Review of the Effect of Posture on Drug Pharmacokinetics: Implications for Clinicians and Clinician-scientists in Drug Development
Favorite
2:00 PM – 3:30 PM
(4-024) Targeted Prescriber and Pharmacist Education for Use of 4-factor PCC in Reversal of Anticoagulation in a Community Hospital
Favorite
2:00 PM – 3:30 PM
(4-043) The Efficacy and Safety of gp2013-rituximab: A Rituximab Biosimilar in a Tertiary Care Hospital in Lebanon
Favorite
2:00 PM – 3:30 PM
(4-067) Topical Application of a Vancomycin Paste for Hemostasis During Cardiothoracic Surgery: A Safety Assessment
Favorite
2:00 PM – 3:30 PM
(4-054) Transition of a Pharmacy Compounding Compliance Platform in a Health System: A Descriptive Journey of Sterile, Non-sterile and Unit Inspection Module Implementation
Favorite
2:00 PM – 3:30 PM
(4-039) Use of an Order Set to Promote Institutional Change in the Standard Monitoring Assay for Intravenous Heparin Infusion at an Academic Affiliated Health System
Favorite
2:00 PM – 3:30 PM
(4-070) What Role Do Pharmacists Have in Caring for Patients with Chronic Conditions? Perceptions of Patients with Cardiovascular Disease and Inflammatory Bowel Disease
Favorite
Back to Top
